175 related articles for article (PubMed ID: 37658695)
1. Cervical precancer and cancer incidence among insured women with and without HIV in South Africa.
Fernández Villalobos NV; Ruffieux Y; Haas AD; Chinogurei C; Cornell M; Taghavi K; Egger M; Folb N; Maartens G; Rohner E
Int J Cancer; 2024 Jan; 154(2):273-283. PubMed ID: 37658695
[TBL] [Abstract][Full Text] [Related]
2. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy.
Nakisige C; Adams SV; Namirembe C; Okoche L; Ferrenberg J; Towlerton A; Larsen A; Orem J; Casper C; Frenkel L; Uldrick TS
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):333-342. PubMed ID: 35195571
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
HIV Med; 2016 Jan; 17(1):7-17. PubMed ID: 26058995
[TBL] [Abstract][Full Text] [Related]
5. Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africa
Rohner E; Mulongo M; Pasipamire T; Oberlin AM; Goeieman B; Williams S; Lubeya MK; Rahangdale L; Chibwesha CJ
Int J Gynaecol Obstet; 2021 Jan; 152(1):53-59. PubMed ID: 33188707
[TBL] [Abstract][Full Text] [Related]
6. Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.
Carlander C; Wagner P; Svedhem V; Elfgren K; Westling K; Sönnerborg A; Sparén P
Int J Cancer; 2016 Oct; 139(7):1471-9. PubMed ID: 27177207
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer risk in women living with HIV across four continents: A multicohort study.
Rohner E; Bütikofer L; Schmidlin K; Sengayi M; Maskew M; Giddy J; Taghavi K; Moore RD; Goedert JJ; Gill MJ; Silverberg MJ; D'Souza G; Patel P; Castilho JL; Ross J; Sohn A; Bani-Sadr F; Taylor N; Paparizos V; Bonnet F; Verbon A; Vehreschild JJ; Post FA; Sabin C; Mocroft A; Dronda F; Obel N; Grabar S; Spagnuolo V; Quiros-Roldan E; Mussini C; Miro JM; Meyer L; Hasse B; Konopnicki D; Roca B; Barger D; Clifford GM; Franceschi S; Egger M; Bohlius J
Int J Cancer; 2020 Feb; 146(3):601-609. PubMed ID: 31215037
[TBL] [Abstract][Full Text] [Related]
9. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
Taku O; Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Businge CB; Williamson AL
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670231
[TBL] [Abstract][Full Text] [Related]
10. The prevention of cervical cancer in HIV-infected women.
Franceschi S; Ronco G
AIDS; 2010 Oct; 24(16):2579-80. PubMed ID: 20940536
[No Abstract] [Full Text] [Related]
11. Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Sparén P; Dillner J
AIDS; 2021 Nov; 35(14):2367-2374. PubMed ID: 34723851
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
Kuhn L; Wang C; Tsai WY; Wright TC; Denny L
AIDS; 2010 Oct; 24(16):2553-61. PubMed ID: 20706107
[TBL] [Abstract][Full Text] [Related]
13. Progress and challenges in human papillomavirus and cervical cancer in southern Africa.
Ramogola-Masire D; Luckett R; Dreyer G
Curr Opin Infect Dis; 2022 Feb; 35(1):49-54. PubMed ID: 34873079
[TBL] [Abstract][Full Text] [Related]
14. Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.
Firnhaber C; Goeieman B; Faesen M; Levin S; Williams S; Rameotshela S; Swarts A; Michelow P; Omar T; Williamson AL; Allan B; Schnippel K; Smith JS
PLoS One; 2016; 11(1):e0144905. PubMed ID: 26730710
[TBL] [Abstract][Full Text] [Related]
15. HPV Types in Cervical Precancer by HIV Status and Birth Region: A Population-Based Register Study.
Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Yilmaz A; Elfgren K; Sönnerborg A; Sparén P; Dillner J
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2662-2668. PubMed ID: 32967862
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
Broshkevitch CJ; Barnabas RV; Liu G; Palanee-Phillips T; Rao DW
PLoS One; 2024; 19(5):e0301997. PubMed ID: 38781268
[TBL] [Abstract][Full Text] [Related]
17. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
[TBL] [Abstract][Full Text] [Related]
18. Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa.
Ibrahim Khalil A; Mpunga T; Wei F; Baussano I; de Martel C; Bray F; Stelzle D; Dryden-Peterson S; Jaquet A; Horner MJ; Awolude OA; Trejo MJ; Mudini W; Soliman AS; Sengayi-Muchengeti M; Coghill AE; van Aardt MC; De Vuyst H; Hawes SE; Broutet N; Dalal S; Clifford GM
Int J Cancer; 2022 Mar; 150(5):761-772. PubMed ID: 34626498
[TBL] [Abstract][Full Text] [Related]
19. Utility of Extended HPV Genotyping as Primary Cervical Screen in an Unscreened Population With High HIV Co-Infection Rate.
Botha MH; Van der Merwe FH; Snyman LC; Dreyer GJ; Visser C; Dreyer G
J Low Genit Tract Dis; 2023 Jul; 27(3):212-216. PubMed ID: 37097217
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
Zhao R; Sekar P; Bennis SL; Kulasingam S
Prev Med; 2023 May; 170():107494. PubMed ID: 37001607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
